Urogen Pharma Ltd. (URGN) — 10-K/A Filings
All 10-K/A filings from Urogen Pharma Ltd.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (2)
-
UroGen Pharma Files 2024 Annual Report Amendment
— Apr 30, 2025 Risk: low
UroGen Pharma Ltd. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 30, 2025, provides upda -
UroGen Pharma Ltd. Files 10-K/A Amendment for Fiscal Year Ended Dec 31, 2023
— Apr 29, 2024 Risk: low
UroGen Pharma Ltd. (URGN) filed a Amended Annual Report (10-K/A) with the SEC on April 29, 2024. UroGen Pharma Ltd. filed an amended 10-K report for the fiscal
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX